Basic Information
LncRNA/CircRNA Name | ENST00000539653.1 |
Synonyms | RP11-230G5.2, LOC105369187 |
Region | GRCh38_12:65499899-65642362 |
Ensemble | NA |
Refseq | NA |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | papillary thyroid cancer |
ICD-0-3 | NA |
Methods | Microarray, qPCR etc. |
Sample | PTC tissues |
Expression Pattern | up-regulated |
Function Description | We selected the top 3 up- and down-regulated lncRNAs and another random 4 differentially expressed lncRNAs and measured their expression in 55 pairs of PTC and corresponding noncancerous thyroid tissues using qRT-PCR. These qRT-PCR results are consistent with the microarray data. |
Pubmed ID | 27929737 |
Year | 2017 |
Title | Long noncoding RNA HIT000218960 promotes papillary thyroid cancer oncogenesis and tumor progression by upregulating the expression of high mobility group AT-hook 2 (HMGA2) gene. |
External Links
Links for ENST00000539653.1 | GenBank HGNC NONCODE |
Links for papillary thyroid cancer | OMIM COSMIC |